Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:919-922
doi: 10.1161/01.HYP.0000013703.07316.7F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyndman, M. E.
Right arrow Articles by Anderson, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyndman, M. E.
Right arrow Articles by Anderson, T. J.
Related Collections
Right arrow Acute coronary syndromes
Right arrow Genetics of cardiovascular disease
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2002;39:919.)
© 2002 American Heart Association, Inc.


Scientific Contributions

The T-786->C Mutation in Endothelial Nitric Oxide Synthase Is Associated With Hypertension

Matthew E. Hyndman; Howard G. Parsons; Subodh Verma; Peter J. Bridge; Steven Edworthy; Charlotte Jones; Eva Lonn; Francois Charbonneau; Todd J. Anderson

From the University of Calgary Departments of Medicine and Medical Genetics (M.E.H., H.G.P., S.V., P.J.B., S.E., C.J., T.J.A.), Calgary, Alberta; Department of Medicine (E.L., F.C.), McGill University, Montreal, Quebec.

Correspondence to Todd J. Anderson, MD, FRCPC, Associate Professor of Medicine, Division of Cardiology, Foothills Hospital, 1403-29th St NW, Calgary, AB CANADA, T2N-2T9. E-mail todd.anderson{at}calgaryhealthregion.ca

Although the pathogenic mechanisms involved in predisposing individuals to hypertension are not well defined, evidence is accumulating that suggests a strong genetic transmission. Animal studies and some clinical investigations have revealed that aberrant NO production may be an important contributing factor. Indeed, a missense mutation in the endothelial NO gene caused by a Glu298Asp alteration has been strongly associated with essential hypertension, coronary artery spasm, and myocardial infarction. Recently, another point mutation caused by a T-786->C transition in the 5'-flanking region of the endothelial NO synthase gene has been identified and, like the Glu298Asp mutation, is associated with coronary artery spasm. The present study was conducted to determine the effect of the T-786->C point mutation on hypertension. We investigated the interaction between the endothelial NO synthase T-786->C polymorphism and blood pressure in a large (n=705) clinically healthy population. Allele frequencies for the T and C alleles were 62% and 38%, translating into 39%, 46% and 15% of the population having the T/T, T/C, and C/C genotypes, respectively, for the T-786->C point mutation. Subjects with the C/C genotype had significantly higher systolic blood pressures and were 2.16(95% confidence interval, 1.3 to 3.7) more likely to be hypertensive. Therefore, the -786 C/C genotype in NO synthase is a significant contributing factor for increasing the risk of essential hypertension.


Key Words: nitric oxide • hypertension, essential • mutation • blood pressure • polymorphism • nitric oxide synthase




This article has been cited by other articles:


Home page
J Bone Joint Surg BrHome page
P. V. Giannoudis, M. van Griensven, E. Tsiridis, and H. C. Pape
The genetic predisposition to adverse outcome after trauma
J Bone Joint Surg Br, October 1, 2007; 89-B(10): 1273 - 1279.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. L. Gonzalez-Sanchez, M. T. Martinez-Larrad, M. E. Saez, C. Zabena, M. J. Martinez-Calatrava, and M. Serrano-Rios
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome
Clin. Chem., January 1, 2007; 53(1): 91 - 97.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. P. Casas, G. L. Cavalleri, L. E. Bautista, L. Smeeth, S. E. Humphries, and A. D. Hingorani
Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Am. J. Epidemiol., November 15, 2006; 164(10): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Zintzaras, G. Kitsios, and I. Stefanidis
Endothelial NO Synthase Gene Polymorphisms and Hypertension: A Meta-Analysis
Hypertension, October 1, 2006; 48(4): 700 - 710.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Cattaruzza, T. J. Guzik, W. Slodowski, A. Pelvan, J. Becker, M. Halle, A. B. Buchwald, K. M. Channon, and M. Hecker
Shear Stress Insensitivity of Endothelial Nitric Oxide Synthase Expression as a Genetic Risk Factor for Coronary Heart Disease
Circ. Res., October 15, 2004; 95(8): 841 - 847.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Song, Y. Yoon, K. U. Park, J. Park, Y. J. Hong, S. H. Hong, and J. Q. Kim
Genotype-specific Influence on Nitric Oxide Synthase Gene Expression, Protein Concentrations, and Enzyme Activity in Cultured Human Endothelial Cells
Clin. Chem., June 1, 2003; 49(6): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Kimura, T. Yokoyama, Y. Matsumura, N. Yoshiike, C. Date, M. Muramatsu, and H. Tanaka
NOS3 Genotype-Dependent Correlation Between Blood Pressure and Physical Activity
Hypertension, February 1, 2003; 41(2): 355 - 360.
[Abstract] [Full Text] [PDF]